Overall these studies demonstrate a strong impact of insulin resistance, hyperglycemia, dyslipidemia, and other hallmarks of T2DM on the pathological effects of Aβ amyloidogenesis as observed in AD. The gene discussed is INS; the disease is Alzheimer disease.